BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 16244497)

  • 1. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.
    Park S; Peng XD; Frohman LA; Kineman RD
    Neuroendocrinology; 2005; 81(6):360-71. PubMed ID: 16244497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autofeedback suppression of growth hormone (GH) secretion in transgenic mice expressing a human GH reporter targeted by tyrosine hydroxylase 5'-flanking sequences to the hypothalamus.
    Szabo M; Butz MR; Banerjee SA; Chikaraishi DM; Frohman LA
    Endocrinology; 1995 Sep; 136(9):4044-8. PubMed ID: 7649113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression of hypothalamic growth hormone (GH)-releasing hormone and somatostatin does not correlate with pulsatile secretion of GH in the adult mouse.
    Murao S; Sato M; Tamaki M; Niimi M; Ishida T; Takahara J
    Res Commun Mol Pathol Pharmacol; 1995 Sep; 89(3):269-77. PubMed ID: 8680796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic growth hormone (GH) hypersecretion induces reciprocal and reversible changes in mRNA levels from hypothalamic GH-releasing hormone and somatostatin neurons in the rat.
    Bertherat J; Timsit J; Bluet-Pajot MT; Mercadier JJ; Gourdji D; Kordon C; Epelbaum J
    J Clin Invest; 1993 Apr; 91(4):1783-91. PubMed ID: 8097209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of episodic growth hormone secretion in streptozotocin-induced diabetic mice: time-course studies on the hypothalamic pituitary axis.
    Murao S; Sato M; Tamaki M; Niimi M; Ishida T; Takahara J
    Endocrinology; 1995 Oct; 136(10):4498-504. PubMed ID: 7664670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary and hypothalamic somatostatin receptor subtype messenger ribonucleic acid expression in the food-deprived and diabetic rat.
    Bruno JF; Xu Y; Song J; Berelowitz M
    Endocrinology; 1994 Nov; 135(5):1787-92. PubMed ID: 7956902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats.
    Sato M; Frohman LA
    Endocrinology; 1993 Aug; 133(2):793-9. PubMed ID: 8102097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
    Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
    Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy.
    Sahu A; Sninsky CA; Kalra PS; Kalra SP
    Endocrinology; 1990 Jan; 126(1):192-8. PubMed ID: 2136723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of hypothalamic neuropeptide-Y neurons by growth hormone in the rat.
    Chan YY; Steiner RA; Clifton DK
    Endocrinology; 1996 Apr; 137(4):1319-25. PubMed ID: 8625906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homologous down-regulation of growth hormone-releasing hormone receptor messenger ribonucleic acid levels.
    Aleppo G; Moskal SF; De Grandis PA; Kineman RD; Frohman LA
    Endocrinology; 1997 Mar; 138(3):1058-65. PubMed ID: 9048609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of ethanol on the growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-I axis in the rat.
    Soszynski PA; Frohman LA
    Endocrinology; 1992 Dec; 131(6):2603-8. PubMed ID: 1359962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats.
    White JD; Olchovsky D; Kershaw M; Berelowitz M
    Endocrinology; 1990 Feb; 126(2):765-72. PubMed ID: 2404748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative regulation of hypothalamic growth hormone-releasing factor messenger ribonucleic acid by growth hormone and insulin-like growth factor I.
    Uchiyama T; Kaji H; Abe H; Chihara K
    Neuroendocrinology; 1994 May; 59(5):441-50. PubMed ID: 7912818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental regulation of pituitary growth hormone-releasing hormone receptor gene expression in the rat.
    Korytko AI; Zeitler P; Cuttler L
    Endocrinology; 1996 Apr; 137(4):1326-31. PubMed ID: 8625907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deprivation of growth hormone-releasing hormone early in the rat's neonatal life permanently affects somatotropic function.
    Cella SG; Locatelli V; Mennini T; Zanini A; Bendotti C; Forloni GL; Fumagalli G; Arce VM; de Gennaro Colonna V; Wehrenberg WB
    Endocrinology; 1990 Oct; 127(4):1625-34. PubMed ID: 1976092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-related alterations in hypothalamic growth hormone-releasing hormone mRNA-but not somatostatin mRNA-expressing cells in genetically obese Zucker rats.
    Tannenbaum GS; Epelbaum J; Videau C; Dubuis JM
    Neuroendocrinology; 1996 Sep; 64(3):186-93. PubMed ID: 8875436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of hypothalamic neuropeptide Y gene expression by insulin.
    Schwartz MW; Sipols AJ; Marks JL; Sanacora G; White JD; Scheurink A; Kahn SE; Baskin DG; Woods SC; Figlewicz DP
    Endocrinology; 1992 Jun; 130(6):3608-16. PubMed ID: 1597158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of alternatively spliced messenger ribonucleic acid encoding truncated growth hormone-releasing hormone receptor in human pituitary adenomas.
    Hashimoto K; Koga M; Motomura T; Kasayama S; Kouhara H; Ohnishi T; Arita N; Hayakawa T; Sato B; Kishimoto T
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2933-9. PubMed ID: 7559877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats.
    Catzeflis C; Pierroz DD; Rohner-Jeanrenaud F; Rivier JE; Sizonenko PC; Aubert ML
    Endocrinology; 1993 Jan; 132(1):224-34. PubMed ID: 8380374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.